RGEN Key Stats
| Income Statement | |
| Revenue TTM | 65.90M |
| Revenue Quarterly YoY Growth | 28.32% |
| EPS Diluted TTM | 0.4821 |
| EPS Diluted Quarterly YoY Growth | 75.00% |
| Net Income TTM | 15.27M |
| Profitability | |
| Gross Profit Margin Quarterly | 54.59% |
| Profit Margin Quarterly | 14.21% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 271.04M |
| Enterprise Value | 238.21M |
| PE Ratio TTM | 17.88 |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 3.222 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | 6.791M |
| Return on Equity | |
RGEN News
- Nasdaq stocks posting largest percentage increases May 13
- Repligen Stock Sees Short Interest Move 24.7% Higher May 10
- REPLIGEN CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Ho... May 10
- Stocks Hitting 52-Week Highs Benzinga May 8
- REPLIGEN CORP Files SEC form 10-Q, Quarterly Report May 7
- Repligen's CEO Discusses Q1 2013 Results - Earnings Call Transcript Seeking Alpha May 3
- Repligen Reports First Quarter 2013 Financial Results noodls May 2
- Repligen Corporation Earnings Call scheduled for 9:00 am ET today May 2
- Repligen Corp (RGEN) Reports Q1 EPS of $0.07; Guides FY13 Street Insider May 2
- InPlay: Repligen reports Q1 results, revs rose 28% YoY to $16.5 mln, provides gu... May 2
RGEN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Repligen Corporation is up 92.41% over the last year vs S&P 500 Total Return up 31.63%, Targacept up 35.19%, and Isis Pharmaceuticals up 129.1%.
RGEN Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these RGEN related companies
Pro Ratings for RGEN
Pro Report PDF for RGEN
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download RGEN Pro Report PDF
Pro Strategies Featuring RGEN
Did Repligen Corporation make it into our Pro Portfolio Strategies?
RGEN Profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Other RGEN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| RGEN | 8.62 | -0.23 | -2.60% | 271.04M |
